What Elevance Health Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 4 |
| Sells | 13 | 18 |
| Total trades | 18 | 74 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 2,627 | 98,468 |
| Disposed | 15,238 | 36,561 |
| Net activity | −12,611 | +61,907 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Kaye Mark | EVP & CFO | Oct 22 | Open-market sale · S | −273 | $447.19 | −$122K | 19,919 |
| Kaye Mark | EVP & CFO | Oct 22 | Open-market sale · S | −827 | $446.05 | −$369K | 20,192 |
| Kaye Mark | EVP & CFO | Oct 22 | Open-market sale · S | −160 | $444.85 | −$71.2K | 21,019 |
| Kaye Mark | EVP & CFO | Oct 22 | Open-market sale · S | −440 | $443.81 | −$195K | 21,179 |
| Kaye Mark | EVP & CFO | Oct 22 | Open-market sale · S | −480 | $442.61 | −$212K | 21,619 |
| Kaye Mark | EVP & CFO | Oct 22 | Open-market sale · S | −2,343 | $441.34 | −$1.03M | 22,099 |
| Kaye Mark | EVP & CFO | Oct 22 | Open-market sale · S | −1,720 | $440.44 | −$758K | 24,442 |
| Kaye Mark | EVP & CFO | Oct 22 | Open-market sale · S | −1,160 | $439.25 | −$510K | 26,162 |
| Kaye Mark | EVP & CFO | Oct 22 | Open-market sale · S | −240 | $438.22 | −$105K | 27,322 |
| Kaye Mark | EVP & CFO | Oct 22 | Open-market sale · S | −560 | $437.07 | −$245K | 27,562 |
| Kaye Mark | EVP & CFO | Oct 22 | Open-market sale · S | −1,660 | $436.20 | −$724K | 28,122 |
| Kaye Mark | EVP & CFO | Oct 22 | Open-market sale · S | −321 | $435.25 | −$140K | 29,782 |
| Kaye Mark | EVP & CFO | Oct 22 | Open-market sale · S | −400 | $434.00 | −$174K | 30,103 |
| Kaye Mark | EVP & CFO | Oct 02 | Grant / award · A | +2,627 | — | — | 30,503 |
| Kaye Mark | EVP & CFO | Oct 02 | Withheld — tax / exercise cost · F | −4,161 | $386.43 | −$1.61M | 27,876 |
| Wessling Erin M | EVP & Chief Legal Officer | Sep 03 | Withheld — tax / exercise cost · F | −255 | $414.78 | −$106K | 7,230 |
| Craig Ryan R | EVP & Chief HR Officer | Sep 02 | Withheld — tax / exercise cost · F | −144 | $405.84 | −$58.4K | 6,530 |
| Wessling Erin M | EVP & Chief Legal Officer | Sep 02 | Withheld — tax / exercise cost · F | −94 | $405.84 | −$38.1K | 7,485 |
| Peru Ramiro G | Director | Jul 17 | Open-market buy · P | +1,000 | $366.05 | +$366K | 10,908 |
| Boudreaux Gail | President and CEO | Jul 17 | Open-market buy · P | +2,045 | $368.25 | +$753K | 171,976 |
Loading...